Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma

被引：2
|
作者：
Ebia, Matthew I. [1 ]
Hitchins, Megan P. [2 ]
Hendifar, Andrew E. [1 ,3 ,4 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA USA
[3] Cedars Sinai Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[4] Cedars Sinai Med Ctr, Dept Med, Div Hematol & Oncol, 8700 Beverly Blvd,Suite 1042AC, Los Angeles, CA 90048 USA
来源：
JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2023年 / 14卷 / 02期
关键词：
Pancreatic ductal adenocarcinoma (PDAC); DNA deficient mismatch repair (DNA dMMR); microsatellite instability (MSI); Lynch syndrome; immunotherapy; CANCER;
D O I：
10.21037/jgo-23-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1175 / 1177
页数：3
相关论文
共 50 条
  • [41] Assessing Influence of Mismatch Repair Mutations on Survival in Patients After Resection of Pancreatic Ductal and Periampullary Adenocarcinoma
    Prezioso, Elizabeth
    Mancheski, Eleanor
    Shivok, Kylee
    Kaplan, Zachary
    Bowne, Wilbur
    Jain, Aditi
    Lavu, Harish
    Yeo, Charles J.
    Nevler, Avinoam
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [42] Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
    Schweizer, Michael T.
    Cheng, Heather H.
    Tretiakova, Maria S.
    Vakar-Lopez, Funda
    Klemfuss, Nola
    Konnick, Eric Q.
    Mostaghel, Elahe A.
    Nelson, Peter S.
    Yu, Evan Y.
    Montgomery, Bruce
    True, Lawrence D.
    Pritchard, Colin C.
    ONCOTARGET, 2016, 7 (50) : 82504 - 82510
  • [43] Neoadjuvant chemo-immunotherapy in mismatch repair deficient (dMMR)/microsatellite instability (MSI) gastric carcinoma (GC): A multicenter retrospective study
    Sun, H.
    Moiseyenko, V.
    Chubenko, V.
    Gerk, I.
    Navmatulya, A.
    Shelekhova, K. V.
    Volkov, N. M.
    Zykov, E.
    Chernobrivceva, V.
    Nered, S.
    Besova, N.
    Obarevich, E.
    Gavrilova, D.
    Kononets, P.
    Stilidi, I.
    Belyak, N.
    Orlova, R. V.
    Topuzov, E.
    Pelipas, Y.
    Tryakin, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S180 - S181
  • [44] Feasibility of non-operative management in patients with localized mismatch repair deficient (dMMR) gastrointestinal (GI) cancer receiving immunotherapy (IO)
    Chakrabarti, S.
    Selfridge, J. E.
    Steinhagen, E.
    Lumish, M.
    Bajor, D.
    Conces, M. L.
    Mohamed, A.
    Hoehn, R.
    Miller-Ocuin, J.
    Mahipal, A.
    Shreenivas, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S203 - S203
  • [45] Immune escape and resistance to immunotherapy in mismatch repair deficient tumors
    Mestrallet, Guillaume
    Brown, Matthew
    Bozkus, Cansu Cimen
    Bhardwaj, Nina
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Genomic alterations in DNA mismatch repair (dMMR)
    Holla, Vijaykumar
    Ronaghy, Arash
    Yang, Richard K.
    Patel, Keyur P.
    Routbort, Mark J.
    Overman, Michael J.
    Dumbrava, Ecaterina E.
    Shaw, Kenna R.
    Karp, Daniel D.
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
    Dionisia Quiroga
    H. Kim Lyerly
    Michael A. Morse
    Current Treatment Options in Oncology, 2016, 17
  • [48] Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer
    Thomas, Jane
    Leal, Alexis
    Overman, Michael J.
    CLINICAL COLORECTAL CANCER, 2020, 19 (02) : 73 - 81
  • [49] "Matching" the "Mismatch" Repair-Deficient Prostate Cancer with Immunotherapy
    Schweizer, Michael T.
    Yu, Evan Y.
    CLINICAL CANCER RESEARCH, 2020, 26 (05) : 981 - 983
  • [50] Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer
    Quiroga, Dionisia
    Lyerly, H. Kim
    Morse, Michael A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (08)
12345